Overexpression of PLOD2 has been observed in laryngeal squamous cell carcinoma, biliary tract cancer, hepatocellular carcinoma, breast cancer, bladder cancer, sarcoma, oral carcinoma, and renal cell carcinoma and is closely related to a poor prognosis. Here, PLOD2 is linked to lip and oral cavity carcinoma.